EPA:DIM Sartorius Stedim Biotech (DIM) Stock Price, News & Analysis → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free DIM Stock Alerts €203.00 -6.70 (-3.20%) (As of 04/30/2024 ET) Add Compare Share Share Today's Range€203.00▼€210.1050-Day Range€196.50▼€280.0052-Week Range N/AVolume51,248 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Sartorius Stedim Biotech alerts: Email Address Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. About Sartorius Stedim Biotech Stock (EPA:DIM)Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.Read More DIM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DIM Stock News HeadlinesApril 30, 2024 | finance.yahoo.comSingle-use Bioreactors Market to hit USD 9.2 Bn by 2032, says Global Market Insights Inc.April 20, 2024 | uk.finance.yahoo.comGlobal Microcarriers Market: Insights into the market's present scenario and future projections (2024-2033)May 2, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.April 20, 2024 | seekingalpha.comSartorius Aktiengesellschaft (SARTF) Q1 2024 Earnings Call TranscriptApril 19, 2024 | wsj.comSartorius Stedim Biotech S.A.April 18, 2024 | finanznachrichten.deSartorius Stedim Biotech publishes unaudited -2-April 18, 2024 | markets.businessinsider.comSartorius Stedim Biotech publishes unaudited first quarter results for 2024April 1, 2024 | msn.comSartorius Stedim Biotech S.A. goes ex dividend tomorrowMay 2, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.March 26, 2024 | markets.businessinsider.comResolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.March 25, 2024 | msn.comFrance stocks lower at close of trade; CAC 40 down 0.00%February 7, 2024 | markets.businessinsider.comBoard of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ MeetingFebruary 6, 2024 | markets.businessinsider.comEQS-Adhoc: SARTORIUS AG: Sartorius launches placement of up to 200 million euros of treasury preference shares through accelerated bookbuildingFebruary 6, 2024 | finanznachrichten.deSartorius Stedim Biotech S.A. announces an -2-January 30, 2024 | morningstar.comSartorius Stedim Biotech SAJanuary 26, 2024 | reuters.comSartorius aims to grow again in 2024 after business slumpJanuary 26, 2024 | finanznachrichten.deSartorius Stedim Biotech publishes preliminary, -3-January 25, 2024 | uk.finance.yahoo.comSartorius Stedim Biotech S.A. (DIM.PA)December 27, 2023 | msn.comFrance stocks mixed at close of trade; CAC 40 up 0.04%December 20, 2023 | markets.businessinsider.comValneva Shareholders Approve EGM Resolutions Including the Transition to a Board of DirectorsDecember 5, 2023 | barrons.comEuropean Pharmas With New Drugs Hold Most Promise in 2024November 21, 2023 | benzinga.comSingle Use Assemblies Market worth $5.2 billion by 2028November 7, 2023 | thestreet.comSartorius Stedim Biotech S.A. ADROctober 19, 2023 | washingtonpost.comShort-Sellers Sink One of Europe’s Hottest StocksOctober 16, 2023 | msn.comMiddle East Tensions: The Ripple Effect on Global Stock MarketsOctober 13, 2023 | marketwatch.comUS Futures Rise Slightly, European Stocks MixedOctober 13, 2023 | marketwatch.comSartorius's Shares Drop on Outlook Cut, Preliminary 3Q DeclinesSee More Headlines Receive DIM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeEPA SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolEPA:DIM CUSIPN/A CIKN/A Webwww.sartorius.com Phone33 4 42 84 56 00FaxN/AEmployees10,662Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Rene Faber (Age 49)CEO & DIrector Comp: $540kMr. Rainer Lehmann (Age 49)CFO & Member of Executive Board Ms. Petra MullerHead of Investor RelationsMs. Petra Kirchhoff (Age 55)Head of Corporate Communications & IR Olivier GuitardHead of Controlling BPSKey CompetitorsEssilor International Société AnonymeEPA:EIFielmann GroupFRA:FIESartorius AktiengesellschaftFRA:SRT3Fresenius SE & Co. KGaAFRA:FREGenfitEPA:GNFTView All Competitors DIM Stock Analysis - Frequently Asked Questions How have DIM shares performed in 2024? Sartorius Stedim Biotech's stock was trading at €239.50 on January 1st, 2024. Since then, DIM shares have decreased by 15.2% and is now trading at €203.00. View the best growth stocks for 2024 here. What other stocks do shareholders of Sartorius Stedim Biotech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius Stedim Biotech investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP). This page (EPA:DIM) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour bank is lying to you.MyBankTrackerThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & CompanyHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sartorius Stedim Biotech S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
